Fluicell AB (publ) (5J90)

Overview

Fluicell AB (publ) establishes its foundation in the life science sector as a pioneering firm dedicated to facilitating advancements in bioprinting and single-cell biology. Founded in 2012 and headquartered in Mölndal, Sweden, Fluicell has made significant strides in developing innovative platforms and offering comprehensive research solutions that cater to the needs of the scientific community. The essence of Fluicell’s mission lies in its commitment to enhancing the understanding and manipulation of single-cell environments, thus opening new avenues for research and discovery in the life sciences domain.

Products and Services

• BIOPEN

  A state-of-the-art microfluidic platform fashioned for the ultra-precise delivery of solutions to single cells. The BIOPEN platform is distinguished by its ability to meticulously control the microenvironment surrounding the cells, thereby facilitating experiments without the need to physically move or cause disturbance to the cells. This platform is pivotal for researchers looking to engage in high-precision studies involving single-cell biology.

• Biozone 6

  This innovative platform is engineered to generate dose-response curves or to study the effects of multiple drug compounds within a controlled setting. Biozone 6 stands out for its capability to employ precise microenvironmental control to dissect drug interactions and effects, thereby enhancing the depth and accuracy of pharmacological studies.

• Dynaflow Resolve System

  An advanced ion channel screening platform that enables the recording of various ion channel currents in a patch-clamp recording configuration. The Dynaflow Resolve System is tailored for scientists and researchers who require a robust and efficient tool for ion channel analysis, providing an unprecedented level of detail and clarity in their experiments.

• Biopixlar

  A leading-edge 3D single-cell bioprinting platform known for its ability to maintain high cell viability and facilitate cell-to-cell communication. Biopixlar is designed for researchers focused on creating complex tissue models and exploring cell interactions within a three-dimensional space, thus offering a new dimension to bioprinting technology and research.

• Biopixlar AER

  An accessible 3D bioprinting platform that is specifically developed to seamlessly integrate into existing laboratory setups, ensuring easy operation within fume hoods or biosafety cabinets. Biopixlar AER brings the sophisticated capabilities of 3D bioprinting into a more compact and user-friendly format, allowing researchers to advance their studies with convenience and efficiency.

In addition to its flagship products, Fluicell also supplies a variety of accessory and consumable products designed to support bioprinting and single-cell biology research, further asserting its role as a comprehensive provider in the life science sector.